CoChat

Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology

Open access
Juliano, R.L., Ming, Xin, Carver, Kyle, Laing, Brian · 2014 · Nucleic Acid Therapeutics
Cited by 128

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

One of the major constraints on the therapeutic use of oligonucleotides is inefficient delivery to their sites of action in the cytosol or nucleus. Recently it has become evident that the pathways of cellular uptake and intracellular trafficking of oligonucleotides can strongly influence their pharmacological actions. Here we provide background information on the basic processes of endocytosis and trafficking and then review recent literature on targeted delivery and subcellular trafficking of oligonucleotides in that context. A variety of approaches including molecular scale ligand-oligonucleotide conjugates, ligand-targeted nanocarriers, and the use of small molecules to enhance oligonucleotide effects are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/nat.2013.0463

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Untitled work

    Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606 · cited 1×

    “Integrins are heterodimeric cell surface proteins that are involved in cell-extracellular matrix (ECM) adhesion, organization of the cytoskeleton, and various signaling processes (Hynes, 2002; Schwartz, 2010).”
    Background
  • Cell Signaling by Receptor Tyrosine Kinases

    Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929

  • Silencing of microRNAs in vivo with ‘antagomirs’

    Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×

    “One important thrust has been the development of conjugates with cholesterol or other lipophilic moieties that promote association with plasma lipoproteins or albumin and can thus enhance uptake into the liver and elsewhere via lipoprotein receptors (Krutzfeldt et al., 2005; Wolfrum et al., 2007; Uno et al., 2011).”
    Background
  • “The clearest example of receptors for oligonucleotides involves the toll-like receptor (TLR) family that is essential for the innate immune response (Robbins et al., 2009; Kawai and Akira, 2011).”
    Background
  • Strategies in the design of nanoparticles for therapeutic applications

    Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · cited 1×

    “Additionally, a variety of polymeric nanoparticles (Kabanov and Vinogradov, 2009) and other types of nanocarriers (Petros and DeSimone, 2010) have been developed for siRNA delivery.”
    Background
  • Rab GTPases as coordinators of vesicle traffic

    Stenmark, H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2728 · Cited by 3,413 · cited 2×

    “Many aspects of trafficking are controlled by members of the large Rab family of GTPases (Stenmark, 2009; Hutagalung and Novick, 2011); this includes vesicle coating or uncoating processes, linkages to the cytoskeleton for movement of vesicles, and membrane recognition and fusion events.”
    Background
  • The druggable genome

    Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · cited 1×

    “Molecules that act on GPCRs comprise approximately 40% of all clinically utilized drugs while GPCRs may account for 28% of the ‘‘druggable genome’’ (Hopkins and Groom, 2002; Filmore, 2004).”
    Background
  • Knocking down barriers: advances in siRNA delivery

    Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115 · cited 2×

    “…is to incorporate the nucleic acid into some form of nanoparticle; potentially this can help to overcome biological barriers, increase cell uptake, and enhance escape from membrane compartments (Akhtar and Benter, 2007; Juliano et al., 2009; Whitehead et al., 2009; Tamura and Nagasaki, 2010).”
    Background
  • Mechanisms of endocytosis

    Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075 · cited 1×

    “Both single and double stranded oligonucleotides usually enter cells by one of several endocytotic pathways (Doherty and McMahon, 2009; Howes et al., 2010; Varkouhi et al., 2011; Juliano et al., 2012a).”
    Background
  • Toxicity of cationic lipids and cationic polymers in gene delivery

    Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · cited 1×

    “A residual concern relates to possible toxicities associated with the cationic polymers or lipids typically used to form nanocarriers for oligonucleotide delivery (Lv et al., 2006; Akhtar, 2010).”
    Background

Show all 18 references

Cited by

See all 128

Metadata

Authors
Juliano, R. L., Ming, X., Carver, K., & Laing, B.
Venue
Nucleic Acid Therapeutics
Published
2014-04
Volume
24
Issue
2
Pages
101-113
ISSN
  • 2159-3337 (ISSN-L)
  • 2159-3345
OpenAlex
W2032596014
Cited by
128
References
18
FWCI
5.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology. https://app.cochat.ai/papers/10.1089/nat.2013.0463
The paper
Juliano, R. L., Ming, X., Carver, K., & Laing, B. (2014). Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2013.0463

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.